Supplements

Mucuna pruriens improves motor symptoms in Parkinson's disease with benefits comparable to levodopa

Mucuna pruriens was supported by Grade A evidence for motor improvement in Parkinson's disease, showing benefits comparable to levodopa and increased ON time without worsening dyskinesia. It also reduced dyskinesia with Grade B evidence.

Last updated: Aug 26, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Plant-derived therapies in Parkinson's disease: a systematic review of clinical evidence.

observational

Sukmueng N, Phokaewvarangkul O, Bhidayasiri R · Journal of neural transmission (Vienna, Austria : 1996) (2026)

Participants: N/A
Duration: N/A
Intervention: Mucuna pruriens (plant-derived therapy)
Outcome: Motor symptoms, ON time, dyskinesia
Effect Size: N/A
Population: Patients with Parkinson's disease

Result:

PubMed: 42489905DOI: 10.1007/s00702-026-03239-4

Mechanism Graph

Mucuna pruriens contains natural levodopa
↓
Provides exogenous dopamine precursor
↓
Increases dopamine availability in the brain
↓
Result: Improved motor function and reduced dyskinesia

Limitations

  • ⚠Evidence grading reflects study hierarchy rather than certainty of clinical effect
  • ⚠Limited number of studies and small sample sizes
  • ⚠Interpretation requires caution due to limited evidence

Frequently Asked Questions

Is Mucuna pruriens as effective as standard levodopa for Parkinson's disease?▼

The study found Mucuna pruriens showed motor benefits comparable to levodopa, with Grade A evidence for motor improvement.

Does Mucuna pruriens worsen dyskinesia in Parkinson's patients?▼

No, the study reported that Mucuna pruriens increased ON time without worsening dyskinesia, and even reduced dyskinesia with Grade B evidence.

What grade of evidence supports Mucuna pruriens for motor symptoms?▼

Grade A evidence supports its use for motor improvement, while Grade B evidence supports reduction of dyskinesia.

Are there any safety concerns with Mucuna pruriens in Parkinson's disease?▼

The abstract does not report specific safety concerns, but notes that overall evidence is limited and interpretation should be cautious.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Sukmueng N, Phokaewvarangkul O, Bhidayasiri R. "Plant-derived therapies in Parkinson's disease: a systematic review of clinical evidence.." Journal of neural transmission (Vienna, Austria : 1996), 2026. PMID: 42489905 DOI: 10.1007/s00702-026-03239-4
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.